Related Experiment Video
Updated: Feb 14, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
Changes in profile of patients seeking alcohol treatment and treatment outcomes following policy changes
Anne-Sophie Schwarz1, Bent Nielsen1, Anette Søgaard Nielsen1
1Unit of Clinical Alcohol Research, Clinical Institute, University of Southern Denmark, J.B. Winsløws Vej 20, Indgang 220B, 5000 Odense, Denmark.
Aim:
In 2007, the legal obligation to deliver alcohol treatment to the public was transferred to the 98 municipalities of Denmark. This resulted in changes in how alcohol treatment centers in Denmark work. The aim of the present study was to describe the patient profiles and treatment outcomes in the alcohol treatment centers regarding regional variation and changes over time.
Subjects And Methods:
This is a descriptive, register-based study of patients enrolled in alcohol treatment centers from 2006-2014 in Denmark. Only patients above the age of 15 years and with a valid postal code were included. The sample was restricted to the patients' first contact with the alcohol treatment register (n = 44,516).
Results:
Patients who initiated treatment in the period 2006-2014 and were registered in the National Alcohol Treatment Register were primarily males (69-70%) with an average age between 46 and 49 years. Most had a vocational education (38-41%) on top of their primary education. The number of years with excessive alcohol use started out as being quite different in the five regions, but became more homogeneous over the study period. Treatment duration in the various regions followed a similar pattern, with all five of them having a similar treatment duration time of 160-230 days by 2014.
Conclusion:
We found that treatment for alcohol use disorder became more homogeneous across the regions in Denmark over time and that by 2014 it was difficult to identify any differences across the country.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Treatment Resistant Cancers
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Alzheimer's Disease: Treatment
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Angle Closure Glaucoma: Treatment

